文献速递糖尿病肥胖与代谢综合征

预测老年糖尿病患者5年和10年死亡风险

Predicting 5- and 10-Year Mortality Risk in Older Adults With Diabetes.
PubMed 文献 · Diabetes Care · 2020-06-19

该研究基于2006年1月1日≥65岁的275,190例退伍军人糖尿病患者,利用行政数据构建并验证5年和10年死亡预后指数。37个预测因子纳入模型,5年和10年死亡C统计量分别为0.74和0.76,校准斜率均为1.01。作者认为该工具可能帮助临床医生和患者制定个体化治疗目标。

要点

  • 在≥65岁退伍军人糖尿病患者中构建了5年和10年死亡预后指数。
  • 预后指数区分度良好,5年和10年死亡C统计量分别为0.74和0.76。
  • 校准斜率均为1.01,观察结局与预测一致。

核心结论

  • 从行政数据获得的预后指数可预测老年糖尿病患者的5年和10年死亡。
  • 该工具可能使临床医生和患者能够制定个体化治疗目标,以平衡治疗强化的风险与获益。

研究设计与样本

  • 研究使用2006年1月1日年龄≥65岁的退伍军人糖尿病患病率样本,共275,190例。
  • 查询行政数据中的潜在预测因子,包括人口学特征、合并症、操作代码、实验室值、人体测量、用药史和既往卫生服务利用。
  • 采用逻辑最小绝对收缩和选择算子回归识别与死亡独立相关的变量,并将所得比值比加权构建5年和10年死亡预后指数。

主要发现

  • 共识别37个死亡预测因子:4个人口学变量、胰岛素或磺脲类或降压药处方、6个生物标志物、既往门诊和住院利用、22个合并症/操作。
  • 预后指数区分度良好,5年和10年死亡的C统计量分别为0.74和0.76。
  • 校准斜率5年和10年死亡均为1.01,观察结局与预测高度一致。

临床怎么用

  • 作者认为该预后指数工具可能使临床医生和患者制定个体化治疗目标,以平衡治疗强化的风险与获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Several diabetes clinical practice guidelines suggest that treatment goals may be modified in older adults on the basis of comorbidities, complications, and life expectancy. The long-term benefits of treatment intensification may not outweigh short-term risks for patients with limited life expectancy. Because of the uncertainty of determining life expectancy for individual patients, we sought to develop and validate prognostic indices for mortality in older adults with diabetes. RESEARCH DESIGN AND METHODS: We used a prevalence sample of veterans with diabetes who were aged ≥65 years on 1 January 2006 (N = 275,190). Administrative data were queried for potential predictors that included patient demographics, comorbidities, procedure codes, laboratory values and anthropomorphic measurements, medication history, and previous health service utilization. Logistic least absolute shrinkage and selection operator regressions were used to identify variables independently associated with mortality. The resulting odds ratios were then weighted to create prognostic indices of mortality over 5 and 10 years. RESULTS: Thirty-seven predictors of mortality were identified: 4 demographic variables, prescriptions for insulin or sulfonylureas or blood pressure medications, 6 biomarkers, previous outpatient and inpatient utilization, and 22 comorbidities/procedures. The prognostic indices showed good discrimination, with C-statistics of 0.74 and 0.76 for 5- and 10-year mortality, respectively. The indices also demonstrated excellent agreement between observed outcome and predictions, with calibration slopes of 1.01 for both 5- and 10-year mortality. CONCLUSIONS: Prognostic indices obtained from administrative data can predict 5- and 10-year mortality in older adults with diabetes. Such a tool may enable clinicians and patients to develop individualized treatment goals that balance risks and benefits of treatment intensification.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Griffith KN, Prentice JC, Mohr DC, et al. Predicting 5- and 10-Year Mortality Risk in Older Adults With Diabetes. Diabetes Care. 2020. PMID: 32669409. doi:10.2337/dc19-1870

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。